Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system

Area of Science:

• Genetics and Molecular Biology
• Stem Cell Research
• Cardiovascular and Muscle Diseases

Background:

• Mutations in the Titin (TTN) gene are a primary genetic driver for a spectrum of cardiomyopathies, including dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathy.
• TTN mutations are also implicated in various skeletal myopathies, highlighting the gene's critical role in cardiac and muscle function.

Purpose of the Study:

• To generate human induced pluripotent stem cell (iPSC) lines with targeted knockouts of the TTN gene.
• To establish a cellular model for investigating the functional consequences of TTN loss-of-function in human cells.
• To provide a platform for studying the pathogenesis of TTN-related cardiomyopathies and skeletal myopathies.

Main Methods:

• Utilized the CRISPR/Cas9 gene-editing system to create three distinct TTN knock-out human iPSC lines.
• Characterized the generated iPSC lines to confirm normal karyotype, typical cellular morphology, and maintained pluripotency.

Main Results:

• Successfully generated three human iPSC lines with complete TTN gene knockout.
• Confirmed that the generated iPSC lines possess normal chromosomal integrity and standard stem cell characteristics.
• Demonstrated the pluripotency of the TTN-knockout iPSC lines, indicating their suitability for further differentiation studies.

Conclusions:

• The developed TTN-knockout iPSC lines serve as a robust and valuable preclinical model.
• These cell lines offer a unique opportunity to dissect the specific roles of Titin in cardiac and skeletal muscle physiology and disease.
• This research facilitates future investigations into therapeutic strategies for TTN-associated genetic disorders.